Affinity Asset Advisors, LLC Portfolio Holdings

Affinity Asset Advisors, LLC

  • $560 Million
  • Q4 2024

Affinity Asset Advisors, LLC has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $560 Million distributed in 85 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Xenon Pharmaceuticals Inc. with a value of $45.5M, Arcellx, Inc. with a value of $32.4M, Alkermes Plc. with a value of $31.6M, Teva Pharmaceutical Industries LTD with a value of $30.9M, and Verona Pharma PLC with a value of $30.7M.

Examining the 13F form we can see an decrease of $19.2M in the current position value, from $579M to 560M.

Affinity Asset Advisors, LLC is based out at New York, NY

Below you can find more details about Affinity Asset Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $560 Million
Healthcare: $492 Million
ETFs: $67.5 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.13B
$45.5 Million 8.14% of portfolio
1,161,237
Q4 2024 Added 1.5%
$2.98B
$32.4 Million 5.78% of portfolio
425,000
Q4 2024 Added 6.25%
$5.45B
$31.6 Million 5.65% of portfolio
1,100,000
Q4 2024 Added 10.0%
$16.7B
$30.9 Million 5.51% of portfolio
1,400,000
Q3 2024 Reduced 3.45%
$3.82B
$30.7 Million 5.48% of portfolio
660,000
Q4 2024 Added 1.54%
$5.61B
$25.5 Million 4.55% of portfolio
82,500
Q4 2024 Reduced 17.5%
$1.87B
$23.5 Million 4.2% of portfolio
460,000
Q4 2024 Added 15.0%
$3.14B
$22.3 Million 3.99% of portfolio
285,000
Q4 2024 Reduced 15.56%
$748M
$18.6 Million 3.32% of portfolio
1,500,000
Q4 2024 Added 7.14%
$1.38B
$18.4 Million 3.28% of portfolio
1,095,924
Q4 2024 Added 13.5%
$720M
$18 Million 3.21% of portfolio
425,000
Q4 2024 Reduced 2.3%
$573M
$17.7 Million 3.17% of portfolio
940,083
Q4 2024 Added 9.26%
$2.05B
$16.4 Million 2.93% of portfolio
389,241
Q4 2024 Added 140.66%
$981M
$12.9 Million 2.3% of portfolio
279,445
Q4 2024 Reduced 3.79%
$404M
$12.1 Million 2.16% of portfolio
630,000
Q4 2024 Added 180.0%
$36.9M
$11 Million 1.97% of portfolio
3,972,318
Q4 2024 Added 40.75%
$623M
$7.97 Million 1.42% of portfolio
2,250,000
Q4 2024 Added 50.0%
$99.9M
$7.71 Million 1.38% of portfolio
2,825,000
Q4 2024 New
$114M
$7.51 Million 1.34% of portfolio
1,575,000
Q4 2024 Reduced 7.35%
$363M
$7.26 Million 1.3% of portfolio
850,512
Q4 2024 Added 183.02%
$5.08B
$6.35 Million 1.13% of portfolio
75,000
Q4 2024 Reduced 6.25%
$186M
$6.27 Million 1.12% of portfolio
2,499,431
Q2 2024 New
$1.46B
$5.64 Million 1.01% of portfolio
300,000
Q4 2024 Reduced 7.69%
$5.2B
$5.49 Million 0.98% of portfolio
200,000
Q4 2024 Reduced 33.33%
$2.4B
$5.02 Million 0.9% of portfolio
130,000
Q4 2024 New
$1.26B
$3.48 Million 0.62% of portfolio
200,000
Q4 2024 New
$10.6B
$3.45 Million 0.62% of portfolio
50,000
Q3 2024 Reduced 60.0%
$366M
$3.21 Million 0.57% of portfolio
263,817
Q2 2024 Added 2.02%
$576M
$3.06 Million 0.55% of portfolio
159,614
Q4 2024 Reduced 69.6%
$1.69B
$2.93 Million 0.52% of portfolio
70,742
Q4 2024 Reduced 5.68%
$3.55B
$2.75 Million 0.49% of portfolio
100,000
Q4 2024 Reduced 55.56%
$61.9M
$2.12 Million 0.38% of portfolio
800,000
Q4 2024 Added 33.33%
$109M
$2.06 Million 0.37% of portfolio
500,000
Q4 2024 Reduced 66.67%
$4.12B
$2.05 Million 0.37% of portfolio
25,000
Q4 2024 Reduced 50.0%
$97.3M
$1.99 Million 0.36% of portfolio
800,000
Q4 2024 Added 23.08%
$14.2M
$1.77 Million 0.32% of portfolio
2,302,598
Q3 2024 Added 36.41%
$1.62B
$1.61 Million 0.29% of portfolio
40,000
Q4 2024 New
$2.67B
$1.6 Million 0.29% of portfolio
50,000
Q4 2024 New
$36.2M
$1.58 Million 0.28% of portfolio
1,000,000
Q4 2024 New
$4.27B
$1.28 Million 0.23% of portfolio
25,000
Q4 2024 Reduced 58.33%
$325M
$1.26 Million 0.23% of portfolio
410,586
Q4 2024 Reduced 41.34%
$58.5M
$1.2 Million 0.21% of portfolio
559,163
Q4 2024 New
$10.5M
$1.01 Million 0.18% of portfolio
1,015,340
Q4 2024 Reduced 23.15%
$932M
$252,000 0.05% of portfolio
9,992
Q4 2024 Reduced 92.01%
$44M
$131,000 0.02% of portfolio
100,000
Q4 2024 Reduced 42.31%
$531M
$98,000 0.02% of portfolio
9,958
Q4 2024 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 6.72%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 65.39%
Syros Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 85
  • Current Value $560 Million
  • Prior Value $579 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 15 stocks
  • Additional Purchases 24 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 20 stocks
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email